microbiology

Bacterial contaminants in cell cultures pose a significant threat to the biopharmaceutical safety. How do scientists detect these hard-to-spot pests?

A team of global scientists found an antibody-based therapeutic that they hope will stop the next rodent-borne hantavirus outbreak in its tracks.

A bacterial inhibitor enhances conventional antibiotics by killing Staphylococcus aureus and stopping a communication system in Pseudomonas aeruginosa.

Gut bacteria tailored to a child’s diet may help treat malnutrition.

Antibiotic resistance is on the rise and scientists are on the lookout for new therapeutics for treating human pathogens. One promising new venture repurposes antimalarial drugs to treat patients with chronic lung diseases such as cystic fibrosis.

People with COVID-19 sometimes lose their sense of smell. But a clinical researcher has a possible solution: the patient’s own blood.

Nanosyringes produced by some bacterial species naturally inject proteins into eukaryotic cells, paving a new frontier for biologic drug delivery.

Researchers face more obstacles studying the lung microbiome than the gut microbiome. One big hurdle is collecting lung samples. In a new study, researchers used an invasive technique to collect fluid from children’s lungs and discovered how the lung’s microbial makeup affects stem cell transplant outcomes.

COVID-19 has gotten a little better at infecting cells and dodging antibodies with each set of mutations in new variants. Omicron is the best at dodging antibodies, but its modified structure sacrificed virulence for antibody resistance.

Just as the delta outbreak subsided, the omicron outbreak peaked. How will we navigate this new pandemic terrain?